Chemicals such as heterocyclic amines (HCA) and polycyclic aromatic amines (PAH) found in overcooked meat play a role in the development of type 2 diabetes (T2D).
Read More »Production Assistant, Diabetes In Control
Statins and Exercise: Revisited
I chronicled someone with type 1 diabetes whose ability to exercise was compromised by his use of statins back in April 2016. As you know, statins are a class of medications prescribed to lower cholesterol levels or abnormal levels of blood fats, with the goal being a reduction in the risk of heart attack and stroke. Brand name examples of statin medications include Altoprev, Crestor, Lescol, Lipitor, Livalo, Mevacor, Pravachol, and Zocor.
Read More »Optimal BP in Type 2 Diabetes and Kidney Disease
A 62-year-old man presents with type 2 diabetes, hypertension, and albuminuria. His seated BP is 162/104 mm Hg. What's an ideal blood pressure target for this patient? A. 140/90 mm Hg B. 130/80 mm Hg C. 120/70 mm Hg D. 150/80 mm HG Follow the link to see the correct answer.
Read More »Type 2 Blood Sugar Monitoring
How often do you recommend to your patients with type 2 who do not take insulin that they monitor their blood glucose? 1) Once daily in the AM 2) Twice daily in the AM and after 1 meal 3) 3 or 4 times daily 2 to 3 times a week 4) Other Follow the link to see how you compare to your colleagues.
Read More »International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #80: Insulin Actions In Vivo: Glucose Metabolism Part 6 of 9
Intravenous glucose: In the presence of euglycemia, insulin displays a potent suppressive action on hepatic glucose production, such that portal insulin concentrations of less than 100 mU L−1 abolish glucose entry into the circulation. Figure 14.7 shows a typical time course for endogenous glucose production following an acute increase in plasma insulin to levels of 60 – 70 mU L−1 in a healthy subject.
Read More »Liraglutide Gets FDA Indication For Reducing CVD Risk, But Not So Fast
The Endocrinologic and Metabolic Drugs Advisory Committee also voted 19-0 that the drug's use in type 2 diabetes patients did not result in excess cardiovascular risk.
Read More »ADA: Alum-GAD (Diamyd) Vaccine Fails to Prevent Type 1 Diabetes
Research will still continue due to its safety.
Read More »ADA: Basal Oral Insulin Tablet Reduces Fasting Blood Glucose and HbA1c Levels Similar to Insulin Glargine in Patients with Type 2
However, in 2016, Novo Nordisk halted the development of their basal oral insulin tablet.
Read More »ADA: Effects of REMD-477, a Glucagon-Blocking Drug, in Patients with Type 1 Diabetes
Results presented in the ADA 77th Scientific Sessions suggests the use of an investigational glucagon-blocking agent can improve glycemic levels and reduce insulin requirements.
Read More »ADA: Efficacy and Safety of Hybrid Closed-Loop Systems in Patients with Type 1 Diabetes
Results from two studies demonstrate improved glycemic control, reduction in nighttime- and exercise-induced hypoglycemia with the use of hybrid closed-loop systems.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.